North Macedonia Reports First Cases of Mpox
North Macedonia reports its first cases of mpox, a viral disease related to smallpox, confirming the importance of ongoing surveillance and public health preparedness.
In a recent development, North Macedonia has documented its first-ever cases of mpox, also known as monkeypox, a viral disease related to smallpox. On May 23, 2025, the country's health authorities confirmed that two male residents of Skopje, aged 40 and 44, tested positive for the virus. Interestingly, both individuals reported no recent travel abroad or connection to each other, indicating potential local transmission. The confirmation came after three different laboratory tests verified the cases.
The Institute for Public Health's director, Marija Andonovska, stated during a press conference that these are the first recorded instances of mpox in North Macedonia. Deputy Health Minister Jovica Andovski reassured the public that the disease is manageable, as there is an established protocol for treatment.
Authorities promptly responded by contacting relevant health institutions and convening a meeting to determine subsequent steps. Mpox, caused by a virus belonging to the same family as smallpox, manifests initially with high fever followed by skin lesions. Historically confined to certain African countries since its identification in the Democratic Republic of Congo in 1970, mpox has gained global attention after spreading more widely from 2022.
The World Health Organization raised its alert level for mpox in 2024, emphasizing the importance of surveillance and preparedness. North Macedonia's first cases highlight the ongoing need for vigilance and public health measures to prevent further spread of the virus.
For more details, visit: https://medicalxpress.com/news/2025-05-north-macedonia-cases-mpox.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Clopidogrel May Surpass Aspirin for Long-Term Management of Coronary Artery Disease
A new study suggests clopidogrel may be more effective than aspirin for long-term prevention of heart attacks and strokes in patients with coronary artery disease, without increased bleeding risk.
IL-10: The Small Protein Playing a Large Role in Preventing Pulmonary Fibrosis
Research reveals that IL-10, a small immune protein produced by lung macrophages, plays a key role in preventing inflammation-driven lung diseases such as pulmonary fibrosis. Understanding IL-10 signaling may lead to new treatments for chronic lung conditions.
Innovative AI and Extended Reality System Enhances Surgical Training for Residents
Mount Sinai researchers have created an AI-powered system using extended reality headsets to teach complex surgical procedures without instructors, demonstrating high success rates and potential to transform surgical education.
Promising New Treatment for Aggressive Acute Myeloid Leukemia Through Clinical Trial Findings
A clinical trial led by Roswell Park has revealed ziftomenib as a promising targeted therapy for aggressive NPM1-mutated acute myeloid leukemia, offering hope for improved patient outcomes.